Interestingly, a study enrolling 76 breast cancer patients reported that overexpression of miR-25*, miR-142-3p, miR-505*, miR-1248, miR-181a-2*, and miR-340* could discriminate between tumor samples from BRCA1/2 mutation carriers and non-carriers [90]. This evidence concerns the gene BRCA1 and breast cancer.